• AGC will promote Senior Executive Officer Tadashi Murano to president and CEO effective Jan. 1, 2027.
• Murano has served as president of the Life Science Company since January 2024.
• Current President and CEO Yoshinori Hirai will become representative director and chairman on Jan. 1, 2027.
• Murano’s appointment as representative director takes effect March 30, 2027, subject to shareholder and subsequent board approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AGC Inc. published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.